The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design
High-dose vitamin D3 supplementation will reduce the risk of hospitalization/death among those with COVID-19 infection. The study involved 1500 newly...
Vitamin D insufficiency as a potential culprit in critical COVID-19 patients
Vitamin D has been implicated in the coronavirus disease- 2019 outcome. We aim to systematically explore the association of vitamin D serum levels wit...
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19
To collate the evidence on the accuracy parameters of all available diagnostic methods for detecting SARS-CoV-2. A systematic review with meta-analysi...
Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review
CVID-19 has created an extraordinary global health crisis. Clinicians and patients are forced to make uninformed decisions. 67.4% (62/92) of women wer...
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review
Altering the gut microbiota has been proposed as a strategy for the treatment of IBS. Family Enterobacteriaceae (phylum Proteobacteria) and genus Bac...
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
The Asia-Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines. It aims to improve inflammatory bowel disease care...
Rifaximin has gained popularity for this indication despite its use is not evidence based. It seems to be effective and safe for the treatment of SIBO.
Palm oil (PO) is used in infant formulas to achieve palmitic acid levels similar to those in human milk. PO is associated with harder stools and SN-2-...
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
Rifaximin has gained popularity for this indication despite its use is not evidence-based. It seems to be effective and safe for the treatment of SIBO...